-
1541
Salvage surgery for esophageal cancer
Published 2018“…Salvage surgery (SALV) is considered the best treatment option in case of persistent or recurrent disease for operable patients, but SALV has been associated with increased morbidity and mortality. The aim of this study is to identify factors linked to outcomes after SALV to better select candidates and to optimize perioperative care. …”
Get full text
Get full text
Get full text
Get full text
article -
1542
-
1543
-
1544
-
1545
-
1546
-
1547
-
1548
-
1549
Effect of Basalt Fibers on The Flexural Behavior of Beams Reinforced With BFRP Bars
Published 2018Get full text
doctoralThesis -
1550
-
1551
-
1552
-
1553
-
1554
-
1555
-
1556
Determinants of Disordered Eating Patterns among an LGTBQ Community in Lebanon
Published 2021Get full text
Get full text
Get full text
masterThesis -
1557
-
1558
-
1559
Acting in the public interest
Published 2019Get full text
Get full text
Get full text
Get full text
article -
1560
Reply to Comments by Kakkar and Dahiya
Published 2014“…TO THE EDITOR: Chahine, Karaoui, and Mansour1 reviewed the efficacy and safety of bedaquiline in the treatment of adults with pulmonary multidrug-resistant tuberculosis (MDR-TB) and generally agree with the comments made by Kakkar and Dahiya.2 Bedaquiline was approved by the Food and Drug Administration based largely on results from phase 2 studies using sputum conversion as a surrogate marker for efficacy rather than long-term mortality data.2 Bedaquiline was shown to be associated with an unfavorable side effect profile, including an unexplained increased risk of mortality, QT prolongation, and elevated liver function tests.2 However, it is important to acknowledge that bedaquiline is the first novel drug to be approved for the treatment of TB in more than 4 decades and the communities devastated by MDR-TB are in desperate need for more options to manage their patients. …”
Get full text
Get full text
Get full text
Get full text
article